In 2024, Peptides OÜ had revenue of 4.1 thousand EUR and loss of 49 EUR. Beneficial owners: Merle Vilepill.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 4,1k € -30.1% | 5,8k € -39.7% | 9,7k € -44.1% |
Profit | -49 € -119.5% | 251 € +1830.8% | 13 € -96.8% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | 3,2k € -1.5% | 3,2k € +8.4% | 3k € +2.1% |
Employees | - | - | - |
Overall rating | B66/100 |
Financial health | 55/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
Negative profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - |
Peptides OÜ is located at Harju maakond, Tallinn, Pirita linnaosa, Vahtriku tee 1-15, 11912.
In 2024, Peptides OÜ had revenue of 4068 EUR and loss of 49 EUR. Compared to previous year, revenue decreased by 30.1%. View full financial report →
The beneficial owners of Peptides OÜ are Merle Vilepill. View ownership details →
No, Peptides OÜ does not have an active VAT number and is not registered as a VAT payer.
Peptides OÜ was founded on January 21, 2015. The company has been operating for 11 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 11 years | 76 - 80 | 61% | |
Net revenue | 4068,00 € | 165 - 169 | 16% | |
Profit | -49,00 € | 128 - 132 | 35% | |
Equity | 3190,00 € | 123 - 127 | 28% | |
Liquidity | 0.01 | - | 10% | |
Profitability | -1.2% | - | 10% | |
Registered capital | 2500,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Merle Vilepill | - | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Merle Vilepill | EE | - |